Virtus Biotech ETF-UsdBBPETF
13F holders, Q4 2024 (December 31)13holders −1
2new positions
3sold out
$60.02avg. 13F price*
At the end of Q4 2024, 13 institutions reported holding Virtus Biotech ETF-Usd Inc. (BBP) in their 13F filings, down 1 from Q3 2024. 2 opened new positions and 3 sold out. The largest holders were CWA Asset Management Group, LLC ($1.5M), Royal Bank of Canada ($1.0M) and Morgan Stanley ($537K).
- Company
- Virtus Biotech ETF-Usd Inc.
- Filed as
- ETFIS SER TR I (Q4 2024)
- CUSIP
- 26923G202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $217K |
| Exits | 3 | $217K |
All 13F filers, Q3 2024 → Q4 2024: 9,305 shares bought and 5,924 shares sold, net +3,381 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| CWA Asset Management Group, LLC | 0.08% | Add +0.7% | 25,457 | $1.5M |
| Royal Bank of Canada | 0.00% | Add +19.6% | 17,091 | $1.0M |
| Morgan Stanley | 0.00% | Add +2.3% | 8,954 | $537K |
| Raymond James Financial Inc. | 0.00% | — | 7,926 | $476K |
| LPL Financial LLC | 0.00% | Add +28.8% | 6,642 | $399K |
| Independent Financial Group, LLC | 0.01% | Add +18.6% | 6,623 | $398K |
| Susquehanna International Group, LLP | 0.00% | Reduce -29.0% | 4,902 | $294K |
| Jag Capital Management, LLC | 0.03% | Reduce -11.8% | 3,553 | $213K |
| Cetera Investment Advisers | 0.00% | New | 3,366 | $202K |
| Cwm, LLC | 0.00% | No change | 717 | $43K |
| UBS Group AG | 0.00% | New | 247 | $15K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 50 | $3K |
| Peoples Bank | 0.00% | No change | 49 | $3K |
"% of holder's portfolio" is BBP's weight in each manager's 13F, not the share of Virtus Biotech ETF-Usd Inc. the manager owns.